Browse 4 Therapeutics companies funded by Mizuho Capital. See funding amounts, founder contacts, and investment details.
A clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies.
CureApp is a digital health and therapeutic medical device software that connects patients and doctors.
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.
View all companies funded by Mizuho Capital across every industry and funding stage.
View Full Mizuho Capital Portfolio